Inhibition of luteinizing hormone release by morphine and endogenous opiates in cultured pituitary cells.
Morphine sulfate was found to have a direct inhibitory effect on both basal and GnRH-stimulated LH release by cultured rat pituitary cells. The inhibitory effect of morphine on LH release was prevented by the opiate antagonist naltrexone, and treatment of cells with naltrexone or beta-endorphin antiserum significantly increased basal LH release. Also, incubation of pituitary cells with CRF caused a significant decrease in basal LH release, an effect that was reversed by naltrexone. Saturable opiate-binding sites were demonstrated in enriched gonadotrophs by [3H]etorphine binding studies. The ability of morphine to inhibit gonadotropin secretion through a direct action on pituitary opiate receptors suggests that long term exposure to exogenous opiates may suppress reproductive function at the hypophyseal level. In addition, the converse effects of CRF and naltrexone or beta-endorphin antiserum on LH release indicate that intrapituitary opioid peptides could exert a paracrine inhibitory action on the gonadotroph.
D000818:Animals; D002478:Cells, Cultured; D004723:Endorphins / Q000276:immunology / Q000502:physiology*; D005048:Etorphine / Q000378:metabolism; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007158:Immunologic Techniques; D007986:Luteinizing Hormone / Q000378:metabolism*; D009020:Morphine / Q000494:pharmacology*; D009271:Naltrexone / Q000494:pharmacology; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D011966:Receptors, LHRH; D011957:Receptors, Opioid / Q000378:metabolism; D001615:beta-Endorphin
D004723:Endorphins; D011956:Receptors, Cell Surface; D011966:Receptors, LHRH; D011957:Receptors, Opioid; D007987:Gonadotropin-Releasing Hormone; D005048:Etorphine; D009271:Naltrexone; D001615:beta-Endorphin; D009020:Morphine; D007986:Luteinizing Hormone